Insider Buying Activity Uncovered - 7 Stocks On The Rise

This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Rare Earth Elements: The Workhorse of The Tech Revolution]( [Read this free investor report to reveal who could benefit in 2024.]( --------------------------------------------------------------- March 21, 2024 Editorial Insights Insider trading occurs when company executives or major shareholders trade stocks based on non-public information. Monitoring these trades provides insight into insiders' expectations for the company's future. For instance, significant purchases before public announcements may indicate anticipated positive news and a potential share price increase. Note: "Insider Buying" is legal stock purchasing by company directors or officers, distinct from illegal insider trading based on non-public information. It's not a crime when based on public information. Insiders, having unique insights, often buy shares when they believe the stock is undervalued. This report lists stocks recently identified with substantial insider buying. --------------------------------------------------------------- Sponsor Message [Author of Get Rich with Dividends Is Giving Away His Ultimate Dividend Package FOR FREE!]( Click Here to Get Marc Lichtenfeld's Ultimate Dividend Package, Including Details on His #1 Dividend Stock... the Safest 9% Dividend in the World... the Top Three "Extreme Dividend" Stocks... and Much, Much More. [For Free.]( --------------------------------------------------------------- [The Cooper Companies, Inc.]( Ticker: [COO]( Recent Price: $101.66 Average Analyst Price Target: $115.60 (13.71%) Market Cap: $20.21B Role Transaction Description No. of Shares Amount Date SVP & CAO Informative Buy Non Open Market Buy 54,724 $3,816,100 2 Days Ago Recent Analyst Action: Issie Kirby, analyst at Redburn Atlantic, reiterates coverage on [The Cooper Companies, Inc. (COO)]( in the Healthcare sector with a Buy rating and a price target of $125 (2 days ago). Here are 3rd party ratings for [COO](: - TipRanks.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 39% (98 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [URGENT: Don't risk your retirement]( looming recession, inflation, unpayable debt, a failing dollar, and a crumbling housing market all put your savings in extreme risk. Protect your retirement with this free guide that shows you how to guard your money against economic downturns with gold. Take action NOW, before it’s too late, Download your free guide and see for yourself why gold is the #1 safe haven for smart investors. [Protect your retirement with this free gold guide]( --------------------------------------------------------------- [Citi Trends, Inc.]( Ticker: [CTRN]( Recent Price: $28.60 Average Analyst Price Target: $28.33 (-0.93%) Market Cap: $244.37M Role Transaction Description No. of Shares Amount Date >10% Owner Informative Buy Non Open Market Buy 114,000 $3,178,332 2 Days Ago Recent Analyst Action: Michael Baker, analyst at D.A. Davidson, reiterates coverage on [Citi Trends, Inc. (CTRN)]( in the Consumer Cyclical sector with a Buy rating (1 day ago). Here are 3rd party ratings for [CTRN](: - TipRanks.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- [AbbVie Inc.]( Ticker: [ABBV]( Recent Price: $176.27 Average Analyst Price Target: $183.25 (3.96%) Market Cap: $311.38B Role Transaction Description No. of Shares Amount Date EVP & CCO Informative Buy Non Open Market Buy 26,110 $1,602,110 2 Days Ago Recent Analyst Action: Robyn Karnauskas, analyst at Truist Financial, reiterates coverage on [AbbVie Inc. (ABBV)]( in the Healthcare sector with a Buy rating (1 week ago). Here are 3rd party ratings for [ABBV](: - TipRanks.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Bottom 26% (186 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Digital Dollar: Convenience or Control?]( the truth behind the digital dollar. Is it a step towards financial innovation or a leap into surveillance and control? See how you can protect yourself and your money with our free guide. [Protect Your Money ASAP]( --------------------------------------------------------------- [RE/MAX Holdings, Inc.]( Ticker: [RMAX]( Recent Price: $7.78 Average Analyst Price Target: $11.00 (41.39%) Market Cap: $142.19M Role Transaction Description No. of Shares Amount Date >10% Owner informative Buy Non Open Market Buy 53,028 $412,560 2 Days Ago Recent Analyst Action: Jason Stewart, analyst at JonesTrading, reiterates coverage on [RE/MAX Holdings, Inc. (RMAX)]( in the Real Estate sector with a Hold rating (2 weeks ago). Here are 3rd party ratings for [RMAX](: - TipRanks.com: Hold - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Bottom 24% (192 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Delcath Systems, Inc.]( Ticker: [DCTH]( Recent Price: $4.25 Average Analyst Price Target: $17.00 (300.00%) Market Cap: $93.70M Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 26,882 $100,001 2 Days Ago Director Informative Buy Non Open Market Buy 26,882 $100,001 2 Days Ago Recent Analyst Action: Marie Thibault, analyst at BTIG, reiterates coverage on [Delcath Systems, Inc. (DCTH)]( in the Healthcare sector with a Buy rating and a price target of $16 (1 month ago). Here are 3rd party ratings for [DCTH](: - TipRanks.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Top 26% (65 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Imminent FDA Decision Could End Obesity in America...]( [...and spark a 224,000% sales surge for one tiny micro-cap stock.]( The Wall Street Journal Reports: The "King Kong" of drugs is coming. Barron's Reports: "it's game changing." [Get the name of the stock here ]( --------------------------------------------------------------- [Arrowhead Pharmaceuticals, Inc.]( Ticker: [ARWR]( Recent Price: $28.16 Average Analyst Price Target: $65.75 (133.49%) Market Cap: $3.49B Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 3,000 $82,990 2 Days Ago Recent Analyst Action: Jason Gerberry, analyst at Bank of America Securities, reiterates coverage on [Arrowhead Pharmaceuticals, Inc. (ARWR)]( in the Healthcare sector with a Buy rating and a price target of $51 (1 week ago). Here are 3rd party ratings for [ARWR](: - TipRanks.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- [Capital Bancorp, Inc.]( Ticker: [CBNK]( Recent Price: $20.44 Average Analyst Price Target: $23.67 (15.79%) Market Cap: $284.58M Role Transaction Description No. of Shares Amount Date Director Informative Buy Options Exercised and fully kept 5,400 $78,516 2 Days Ago Recent Analyst Action: Catherine Mealor, analyst at KBW, reiterates coverage on [Capital Bancorp, Inc. (CBNK)]( in the Financial Services sector with a Hold rating and a price target of $25 (1 month ago). Here are 3rd party ratings for [CBNK](: - TipRanks.com: Hold - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Sell, Bottom 27% (182 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Blue Chips And Billionaires Quietly Investing In "The New Oil"]( re as essential to the tech and AI revolutions as oil was to the industrial revolution. Known as rare earth elements or REEs, these relatively unheard of commodities are essential to semiconductor chips, renewable energy, electric vehicles, and more. [Learn more about the global race to secure supply and what it means for investors.]( --------------------------------------------------------------- And there you have it. To Your Financial Freedom, The Editor MarketInsidersPress.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. [If you are not a human, click here.]( By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. This is part of your free subscription to MarketInsidersPress.com MarketInsidersPress.com 1519 Mecklenburg Hwy Unit 4 | Mt. Mourne | NC | 28123 | United States | 877 411 9808 MarketInsidersPress.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mount Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software